The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | Potential strategies to prevent the evolution of CCUS to MDS
Guillermo Garcia-Manero, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses potential methods for delaying the progression of clonal cytopenia of undetermined significance (CCUS) into myelodysplastic syndromes (MDS), including early administration of low-dose lenalidomide. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
